Suppression of Aβ-induced monocyte neurotoxicity by antiinflammatory compounds

Journal of Neuroimmunology

Volumn 80, Issue 1-2, 1997, Pages 6-12

  Dzenko, K A ^a   Weltzien, R B ^a   Pachter, J S ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Alzheimer disease; Beta amyloid; Macrophages, antiinflammatory; Neorotoxicity

Indexed keywords

AMYLOID BETA PROTEIN; ANTIINFLAMMATORY AGENT; COLCHICINE; DEXAMETHASONE; INDOMETACIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; MONOCYTE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SENILE PLAQUE;

AMYLOID BETA-PROTEIN; ANIMALS; ANTI-INFLAMMATORY AGENTS; CEREBRAL CORTEX; COCULTURE TECHNIQUES; COLCHICINE; DEXAMETHASONE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INDOMETHACIN; MONOCYTES; NEUROTOXINS; ORGAN CULTURE TECHNIQUES; RATS; RATS, INBRED STRAINS; SOLUBILITY;

EID: 0031458175     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00128-8     Document Type: Article

References (50)

1. Aisen P.S., Davis K.L. Inflammatory mechanisms in Alzheimer's disease: Implications for therapy. Am. J. Psychiatry. 151:1994;1105-1113.
2. Alsharif N.F., Hassoun E., Bagchi M., Lawson T., Stohs S.J. The effects of anti-TNF-alpha antibody and dexamethasone on TCDD-induced oxidative stress in mice. Pharmacology. 48:1994;127-136.
3. Balazs L., Leon M. Evidence for an oxidative challenge in the Alzheimer's brain. Neurochem. Res. 19:1994;1131-1137.
4. Banati R.B., Gehrmann J., Schubert P., Kreutzberg G.W. Cytotoxicity of microglia. Glia. 7:1993;111-118.
5. Becker K., Luederkens G., Grupe R., Foster W. PAF-induced death in NMRI mice - A suitable shock model for testing new PAF receptor antagonists. Correlation with eicosanoid related substances. Prostaglandins Leukotrienes Essent. Fatty Acids. 48:1993;265-271.
6. Benvensite, E., 1993. Astrocyte-microglia interactions. In: Murphy, S. (Ed.), Astrocytes Pharmacology and Function. Academic Press, Inc., San Diego, CA, pp. 355-382.
7. Blass J.P., Gibson G.E. Oxidative abnormalities in Alzheimer's disease. Rev. Neurol. 147:1991;513-525.
8. Boumpas D.T., Chrousos G.P., Wilder R.L., Cupps T.R., Balow J.E. Glucocorticoid therapy for immune-mediated diseases: Basic and clinical correlates. Ann. Intern. Med. 119:1993;1198-1208.
9. Bruning, J.L., Kintz, B.L., 1977. Computational Handbook of Statistics, 2nd ed. Scott, Foresman and Company, Glenview, IL, pp. 122-124.
10. Denholm E.M., Wolber F.M. A simple method for the purification of human peripheral blood monocytes. A substitute for Sepracell-MN. J. Immunol. Methods. 144:1991;247-251.
11. Dustin, P., 1984. Microtubules, 2nd ed. Springer-Verlag, Berlin, New York, pp. 171-190.
12. Fukumoto H., Asami-Odaka A., Suzuki N., Iwatsubo T. Association of A beta 40-positive senile plaques in the brains of patients with Alzheimer's disease and in non-demented aged individuals. Neurodegeneration. 5:1996;7-13.
13. Gelbard H.A., Nottet H.S.L.M., Swindells S., Jett M., Dzenko K.A., Genis P., White R., Wang L., Choi Y.B., Zhang D. Platelet activating factor: A candidate HIV-1-induced neurotoxin. J. Virol. 68:1994;4628-4635.
14. Giulian D., Robertson C. Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord. Ann. Neurol. 27:1990;33-42.
15. Giulian D., Haverkamp L.J., Li J., Karshin W.L., Yu J., Tom D., Li X., Kirkpatrick J.B. Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem. Int. 27:1995;119-137.
16. Hensley K., Butterfield D.A., Hall N., Cole P., Subraniam R., Mark R., Mattson M.P., Markesbery W.R., Harris M.E., Aksenov M., Aksenova M., Wu J.F., Carney J.M. Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer's disease-associated peptide. Ann. N.Y. Acad. Sci. 786:1996;120-134.
17. Ii M., Sunamoto M., Ohnishi K., Ichimori Y. β-amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity. Brain Res. 720:1996;93-100.
18. Insel, P.A., 1996. Analgesic-antipyretic and antiinflammtory agents and drugs employed in the treatment of gout. In: Hardeman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W., Gilman, A.G. (Eds.), Goodman and Gilman's The Pharmacological Basic of Therapeutics, 9th ed. McGraw-Hill, New York, pp. 617-657.
19. Jungi T.W., Adler H., Adler B., Thony M., Krampe M., Peterhans E. Inducible nitric oxide synthase of macrophages. Present knowledge and evidence for species-specific regulation. Vet. Immunol. Immunopathol. 54:1996;323-330.
20. Kankaaranta H., Moilanen E., Vapaatalo H. Effects of non-steroidal antiinflammatory drugs on polymorphonuclear leukocyte functions in vitro. Naunyn-Schmiedeberg's Arch. Pharmacol. 350:1994;685-691.
21. Khoury J.E., Kickman S.E., Thomas C.A., Cao L., Siverstein S.C., Loike J.D. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature. 382:1996;716-719.
22. Klegeris A., Walker D.G., McGeer P.L. Biochem. Biophys. Res. Commun. 199:1994;984-991.
23. Laskin D.L., Pendino K.J. Macrophages and inflammatory mediators in tissue injury. Ann. Rev. Pharm. Toxicol. 35:1995;655-677.
24. Lee S.C., Dickson D.W., Liu W., Brosnan C.F. Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. J. Neuroimmunol. 46:1993;19-24.
25. Liu B.J., Zheng M.R., Zhang S.Z., Dai F.P. Effects of antipsoriatic drugs on biosynthesis of platelet activating factor by human keraatinocytes. Chin. Med. J. 107:1994;26-331.
26. London J.A., Biegel D., Pachter J.S. Neurocytopathic effects of β-amyloid-stimulated monocytes: A potential mechanism for central nervous system damage in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 93:1996;4147-4152.
27. Lopez-Moratalla N., Calleja A., Gonzalez A., Perez-Mediavilla L.A., Aymerich M.S., Burrel M.A., Santiago E. Inducible nitric oxide synthase in monocytes from patients with Graves' disease. Biochem. Biophys. Res. Commun. 226:1996;723-729.
28. Masayuki I., Sunamoto M., Ohnishi K., Ichimori Y. β-Amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity. Brain Res. 720:1996;93-100.
29. McGeer P.L., McGeer E.G. The inflammatory response of the brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. 21:1995;195-218.
30. McGeer P.L., Itagaki S., Tago H., McGeer E.G. Reactive microglia in patients with senile dementia of Alzheimer type are positive for the histocompatibility protein HLA-DR. Neurosci. Lett. 79:1987;195-200.
31. McGeer P.L., McGeer E., Rogers J., Sibley J. Antiinflammatory drugs and Alzheimer's disease. Lancet. 335:1991;1037.
32. Meda L., Cassatella M.A., Szendrei G.I., Otvos L. Jr., Baron P., Villalba M., Ferrari D., Rossi F. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature. 374:1995;647-650.
33. Michikawa M., Lim K.T., McLarnon J.G., Kim S.U. Oxygen radical-induced neurotoxicity in spinal cord neuron culture. J. Neurosci. Res. 37:1994;62-70.
34. 2 and by cyclooxygenase inhibitors. Glia. 19:1997;152-160.
35. Moilanen E., Moilanen T., Knowles R., Charles I., Kadoya Y., al-Saffar N., Revel P.A., Moncada S. Nitric oxide synthase is expressed in human macrophages during foreign body inflammation. Am. J. Pathol. 150:1997;881-887.
36. Narumi S., Hamilton T.A. Dexamethasone selectively regulates LPS-inducible gene expression in murine peritoneal macrophages. Immunopharmacology. 19:1990;93-101.
37. Norris D.A., Weston W.L., Sams W.M. Jr. The effect of immunosuppressive and antiinflammatory drugs on monocyte function in vitro. J. Clin. Lab. Med. 90:1977;569-580.
38. Nottet H.S., Jett M., Flanagan C.R., Zhai Q.H., Persidsky Y., Rizzino A., Bernton E.w., Genis P., Baldwin T., Schwartz J., Gendelman H. A regulatory role for astrocytes in HIV-1 encephalitis. An overexpression of eicosanoids, platelet activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J. Immunol. 154:1995;3567-3581.
39. Pachter J.S. Inflammatory mechanisms in Alzheimer disease: The role of beta-amyloid glial interactions. Mol. Psychiat. 2:1997;91-95.
40. Paresce D.M., Ghosh R.N., Maxfield F.R. Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor. Neuron. 17:1996;553-565.
41. Perlmutter L.S., Barron E., Chui H.C. Morphologic association between microglia and senile plaque amyloid in Alzheimer disease. Neurosci. Lett. 119:1990;32-36.
42. Rizzo A., Taylor A.E., Townsley M.I., Logsdon P., Khimenko P.L., Fletcher J.R. Platelet activating factor increases vascular resistance in rat hindquarters by thromboxane A2. Am. J. Physiol. 268:1995;H1954-1958.
43. Rogers J. Inflammation as a pathogenic mechanism on Alzheimer's disease. Arzneim.-Forsch. Drug Res. 45:1995;439-442.
44. Rogers J., Kirby L.C., Hempleman S.R., Berry D.L., McGeer P.L., Kasniak A.W., Zalinski J., Cofield M., Manuskhani L., Wilson P., Kogan F. Clinical trial of indomethacin in Alzheimer's disease. Neurol. 43:1993;1609-1611.
45. Siesjo B.K., Agardh C.-D., Bengtsson F. Free radicals and brain damage. Cerebrovasc. Brain Metab. Rev. 1:1989;165-211.
46. Styren S.D., Civin W.H., Rogers J. Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer disease brain. Exp. Neurol. 110:1990;93-104.
47. Susuki M., Li J., Asakura T., Arai K. Opposing effects of indomethacin and nordihydroguaiaretic acid on macrophage function and tumor growth. Jpn. J. Can. Res. 85:1994;306-314.
48. 2 and a β-adrenergic agonist. Glia. 11:1994;383-386.
49. Wisniewski H.M., Barcikowska M., Kida E. Phagocytosis of beta/A4 amyloid fibrils of the neuritic cortical plaques. Acta Neuropathol. 81:1991;588-590.
50. Zemer D., Pras M., Sohar E., Modon M., Cabili S., Gafni J. Colchicine in the prevention of and treatment of amyloidosis of familial Mediterranean fever. New Engl. J. Med. 314:1986;1001-1005.